Alpharma Inc., of Bridgewater, N.J., appointed Ron Warner executive vice president and chief scientific officer and named R. Scott Shively senior vice president of pharmaceutical commercial operations...Althea Technologies Inc., of San Diego, named E. J. Brandreth vice president of quality and regulatory

Javelin Pharmaceuticals Inc., of Cambridge, Mass., named Daniel Carr president and said Fred Mermelstein assumed the role of executive director...Oncothyreon Inc., of Bellevue, Wash., named Daniel K. Spiegelman and Stephen K. Burley to its board...Pantec Biosolutions AG, of Ruggell, Leichtenstein, appointed Burkhard Feurstein and Michael Armbruester to its board

Adolor Corp., of Exton, Pa., promoted Lee Techner to vice president of medical affairs and medical director...It also named Guido Magni to its board and the governance and nominating committee

VirtualHealth Technologies Inc., of Lexington, Ky., named Robert Tapales vice president of operations. Westfield Capital Management, of Boston, named Lawrence C. Fritz Life Sciences Venture Partner. WuXi PharmaTech, of Shanghai, China, appointed Peng Wang vice president of discovery biology. XTL Biopharmaceuticals Ltd., of Valley College, N.Y., appointed Laurence N. Charney to its board.

Stem Cell Therapeutics Corp., of Calgary, Alberta, named Thomas Franck vice president of commercial planning. Trius Therapeutics Inc., of San Diego, appointed Paul Truex to its board. VentiRx Pharmaceuticals Inc., of San Diego, named Elliott Grossbard to its board.

Premier Research Group plc, of Philadelphia, appointed Anthony Faragasso, executive director and global head of medical management and safety...Somnus Therapeutics Inc., of Bedminster, N.J., named Gary Cupit, Mary Osbakken, Christine Blumhardt, Linda Hogan and Anne McCormick to its executive development team

Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Georges Gemayel, CEO and member of the board...Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Raymond T. Keane vice president, general counsel and chief compliance officer...Endo Pharmaceuticals Holdings Inc., of Chadds Ford, Pa., named Blaine T. Davis vice president of investor relations and corporate communications

Dyax Corp., of Cambridge, Mass., named Mark J. Sawyer as senior vice president of process sciences and technical operations

Egenix Inc., of New York, appointed Donald C. Fresne chairman and CEO and named Daniel Petrylak chairman of its scientific advisory board...GeneNews Ltd., of Toronto, elected Harry A. Glorikian and Fran Tuttle to its board

and Stark will continue as president and member of the board...Hoon Han, of Histostem, will be chairman of the board and CEO of AmStem International

Senomyx Inc., of San Diego, appointed Roger D. Billingsley director and a member of the corporate governance and nominating committee...The company also named Kent Snyder chairman of the board and Jay M. Short lead independent director

Medivation Inc., of San Francisco, appointed Michele D. Bronson vice president, regulatory and quality...Minrad International Inc., of Orchard park, N.Y., appointed David T. DiGiacinto president and chief operating officer...Monogram Biosciences Inc., of South San Francisco promoted Gordon Parry to vice president, research and development, oncology

Febit group, of Medford, Mass., and Heidelberg, Germany, announced its new scientific advisory board with Mark Chee chairman, Karoly Nikolich vice chairman and David Lockhart, Mostafa Ronaghi and Jeffrey Trent as members

Adventrx Pharmaceuticals Inc., of San Diego, named Mark Bagnall executive vice president and chief financial officer...Agendia BV, of Amsterdam, the Netherlands, appointed Richard A. Bender vice president and chief medical officer...Synthetic Genomics Inc., of La Jolla, Calif., appointed Chuck McBride executive vice president and chief financial officer

MPM Capital, of Boston, appointed Robert Millman and Elizabeth Stoner executive partners...Oragenics Inc., of Alachua, Fla., appointed Derek Hennecke and Stanley B. Stein to its board of directors...Predictive Biosciences, of Lexington, Mass., appointed Peter Klemm president, director and CEO

The company also established a strategic commercialization and partnership committee consisting of directors Peter D. Kiernan III, Neil W. Flanzraich and Georg Nebgen...Modigene Inc., of Nes-Ziona, Israel, named Marian Gorecki and Steven D. Rubin to its board and appointed Phillip Frost chairman

Memory Pharmaceuticals Corp., of Montvale, N.J., appointed Vaughn M. Kailian interim president and CEO...Jim Sulat, the previous president and CEO, will be chief financial executive on a part-time basis...OPKO Health Inc., of Miami, appointed Thomas E. Beier and Richard C. Pfenniger Jr

John C. Brown and A. Lad Burgin are retiring from the board...Eileen Valenta vice president, operations and compliance, regulatory affairs...and Shou-Bai Chao vice president of vaccine manufacturing

Affitech AS, of Oslo, Norway, appointed Sergej Kiprijanov vice president of discovery research and preclinical development...Alnylam Pharmaceuticals Inc., of Cambridge, Mass., appointed Edward Scolnick to its board of directors and scientific advisory board...AlphaVax, of Research Triangle Park, N.C., appointed Mark Schleiss, David Bernstein, Robert Pass and Paul D. Griffiths to its cytomegalovirus advisory board and named Robert Olmsted as chairman